Csenge Advisory Group’s Repligen RGEN Stock Holding History

Csenge Advisory Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14	Closed	–	–	1187
2018 Q3	$0	Buy	+14	New	+$722	﹤0.01%	1498

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Csenge Advisory Group's RGEN Position: Q4 2018 in Review

Csenge Advisory Group sold out of Repligen (RGEN) in Q4 2018, closing a stake of 14 shares.

Csenge Advisory Group first reported a position in RGEN in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 242 funds tracked by Wall St. Rank hold RGEN as of Q4 2018.

Csenge Advisory Group reported no remaining Repligen position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 14 Repligen shares in Q4 2018.
Csenge Advisory Group first reported a position in Repligen in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Repligen position peaked at $0 in Q3 2018.
242 funds tracked by Wall St. Rank held Repligen as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.